Description

The global epidemic trend shows that cardiovascular disease has become one of the serious threats to human health whose incidence and death rate has exceeded that of malignant tumor and leapt to the first. According to the World Health Organization (WHO), about 17 million people die of cardia-cerebrovascular disease, among which 50% die of acute myocardial infarction and cerebral infarction each year in the world. Phosphocreatine, developed by Alfa Wassermann in 1997, has the largest market share compared with other cardiovascular drugs.

View Full Report at: http://www.marketresearchreports.biz/analysis/289103

According to CRI’s survey, phosphocreatine develops fast after entering China with annual sales value rising from less than CNY 30 million in 2005 to CNY 1.37 billion in 2014 and CAGR during the period of 2005-2014 reaching up to 53.7%. Phosphocreatine enjoys a vast demand in China. Beijing Lifeshine Pharmaceutical Co., Ltd, Haikou Qili Pharmaceutical Co., Ltd, Hebei Tiancheng Pharmaceutical Co., Ltd, Harbin Bolai Pharmaceutical Co., Ltd and Jilin Yinglian Biopharmaceutical Co., Ltd all occupy certain shares of the market, among which Jilin Yinglian Biopharmaceutical Co., Ltd has the largest market share of over 40% with sales value in 2014 reaching up to CNY 560 million. However, Alfa Wassermann (Italy), the original developer of phosphocreatine, had a market share less than 3% in China in 2014.

As Chinese people’s living standards improve and the population ages, the incidence of cardiovascular will keep increasing and the market size of phosphocreatine in China will keep expanding too.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289103

Readers can get at least the following information through this report:

market share of manufacturers of phosphocreatine in Chinese market
price of phosphocreatine in Chinese market
major manufacturers of phosphocreatine in China
share of different dosage forms of phosphocreatine in Chinese market
market outlook of phosphocreatine in China

The author suggests the following groups of people purchase this report:

manufacturers of drugs for cardiovascular disease
investors/ research institutions interested in Chinese medicine market
any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Phosphocreatine
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Phosphocreatine in China
2.1 Patent and Approval Status of Phosphocreatine in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Phosphocreatine in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz


Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]